DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Sarrazin C, Schwendy S, Müller B et al.
Improved responses to pegylated interferon alfa-2b and ribavirin by individualizing treatment for 24–72 weeks.
Gastroenterology 2011; epub.
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.